140,000,000 CREDIT FACILITY CREDIT AGREEMENT Dated as of August 4, 2021 by and among AMPHASTAR PHARMACEUTICALS, INC., TOGETHER WITH THE OTHER PERSONS THAT ARE NOW OR FROM TIME TO TIME BECOME BORROWERS HEREUNDER, as Borrowers, THE OTHER PERSONS PARTY...Credit Agreement • November 9th, 2021 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2021 Company Industry JurisdictionThis CREDIT AGREEMENT (including all exhibits and schedules hereto, as the same may be amended, modified and/or restated from time to time, this “Agreement”) is entered into as of August 4, 2021, by and among Amphastar Pharmaceuticals, Inc., a Delaware corporation (“Amphastar”; together with each other entity that from time to time becomes a borrower under this Agreement in accordance with the terms hereof, collectively, the “Borrowers” and individually a “Borrower”), the other Persons party hereto that are designated as a “Credit Party”, Capital One, National Association, a national banking association (in its individual capacity, “Capital One”) as Agent for the several financial institutions from time to time party to this Agreement (collectively, the “Lenders” and individually each a “Lender”) and for itself as a Lender (including as Swing Lender) and such Lenders.
Share Purchase AgreementShare Purchase Agreement • November 9th, 2021 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 9th, 2021 Company Industry